Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06170190
What this trial is testing

A Multicentre,Study of IBI133 in Subjects WithUnresectable, Locally Advanced or Metastatic SolidTumours

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd. 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07272590
What this trial is testing

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Qilu Pharmaceutical Co., Ltd. 290
Early research (Phase 1)Active Not RecruitingNCT00777582
What this trial is testing

Phase I Comparative Bioavailability Study

Who this might be right for
Solid Tumors
AstraZeneca 197
Testing effectiveness (Phase 2)Study completedNCT00484276
What this trial is testing

Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 57
Early research (Phase 1)Study completedNCT02675491
What this trial is testing

Phase 1 Study of DS-6051b in Japanese Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Advanced Solid Malignant Tumors
Daiichi Sankyo Co., Ltd. 15
Early research (Phase 1)Ended earlyNCT01243762
What this trial is testing

Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)

Who this might be right for
Neoplasms Malignant
Merck Sharp & Dohme LLC 47
Not applicableLooking for participantsNCT06342440
What this trial is testing

Early Detection of Advanced Adenomas and Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Polyp+15 more
City of Hope Medical Center 2,000
Testing effectiveness (Phase 2)Study completedNCT00306891
What this trial is testing

Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)

Who this might be right for
Cancer
AstraZeneca 60
Early research (Phase 1)Study completedNCT05144061
What this trial is testing

A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumor
Shanghai Hengrui Pharmaceutical Co., Ltd. 28
Early research (Phase 1)Study completedNCT04126668
What this trial is testing

Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

Who this might be right for
Advanced Malignant Solid Tumors
AnewPharma 24
Early research (Phase 1)Not Yet RecruitingNCT06691360
What this trial is testing

AK137 (Bispecific Antibody Targeting CD73 and LAG-3) in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Akeso 87
Testing effectiveness (Phase 2)Looking for participantsNCT07326488
What this trial is testing

MHB009C in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd 200
Early research (Phase 1)Study completedNCT03333824
What this trial is testing

Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer

Who this might be right for
Solid Tumours
AstraZeneca 33
Early research (Phase 1)Looking for participantsNCT06821048
What this trial is testing

Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerStomach CancerPancreatic Cancer+1 more
Weijia Fang, MD 18
Early research (Phase 1)UnknownNCT04275050
What this trial is testing

Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets

Who this might be right for
Advanced Malignant Solid Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 40
Early research (Phase 1)Study completedNCT04414150
What this trial is testing

A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant Tumours

Who this might be right for
Malignant Tumours
Jiangsu HengRui Medicine Co., Ltd. 28
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Not applicableNot Yet RecruitingNCT07692776
What this trial is testing

SYH2095 for Advanced Malignant Tumors: Phase I Study

Who this might be right for
Advanced Malignant Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 140
Early research (Phase 1)Study completedNCT01648764
What this trial is testing

LY2334737 in Participants With Cancer That is Advanced and/or Has Spread

Who this might be right for
Malignant Solid TumorSolid TumorMetastatic Tumor
Eli Lilly and Company 73
Early research (Phase 1)UnknownNCT05499715
What this trial is testing

A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors

Who this might be right for
Advanced Tumor of Digestive Tract or Urinary System
Chinese Academy of Medical Sciences 48
Next Page